Azimuth is a precision research and intelligence company that connects patient-level data across the evidence continuum, from real-world evidence generation to prospective trial recruitment. The company embeds continuous, adaptive research into real-world healthcare ecosystems, unifying multi-modal, patient-level data with advanced analytics and clinical execution. Azimuth's partner network provides access to 500+ global facilities, 10 million patients, 43+ million annual encounters, and one of the world’s largest biorepositories.
Funding
Funding not disclosed
Founders
Product
Problem
Biopharmaceutical companies face fragmented, siloed patient data across the product lifecycle, making it difficult to generate high-integrity real-world evidence and efficiently recruit for prospective trials. This disconnection slows therapy development, delays regulatory and payer decisions, and limits the ability to optimize treatments for real-world patient populations.
Solution
Azimuth delivers precision research and intelligence by connecting patient-level data across the evidence continuum—from real-world evidence generation to prospective trial recruitment. The company builds a next-generation evidence engine for biopharma that embeds continuous, adaptive research into real-world healthcare ecosystems. By unifying multi-modal, patient-level data with advanced analytics and clinical execution, Azimuth accelerates the discovery, development, and lifecycle optimization of therapies. Its approach supports regulatory, payer, and clinical decisions while enabling clinical research at the point of care, resulting in faster timelines Tags and richer patient-level data for improved outcomes globally.
Target Audience
Primary customers are biopharmaceutical companies seeking real-world evidence generation, prospective trial recruitment, and product lifecycle optimization services.
Features
- Access to patient-level, multi-modal data supporting regulatory, payer, and clinical decisions across the full product lifecycle
- Conducts clinical research at the point of care for faster timelines and richer patient-level data
- Partner ecosystem includes 500+ global facilities, 10 million patients, and 43+ million annual encounters
- One of the world’s largest biorepositories available through partner network
- Advanced analytics and clinical execution embedded within real-world healthcare ecosystems
- Continuous, adaptive research model that accelerates discovery, development, and lifecycle optimization